Alexandre Grassin
Corporate Officer/Principal chez Calliditas Therapeutics Suisse SA
Postes actifs de Alexandre Grassin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Chief Administrative Officer | 04/01/2012 | - | |
Director of Finance/CFO | 04/01/2012 | 14/01/2015 |
Historique de carrière de Alexandre Grassin
Anciens postes connus de Alexandre Grassin
Sociétés | Poste | Début | Fin |
---|---|---|---|
ENGENE HOLDINGS INC. | Director of Finance/CFO | 01/07/2023 | 29/11/2023 |
Alexion Pharma GmbH | Corporate Officer/Principal | 01/01/2010 | 01/01/2012 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2007 | 01/01/2010 |
GENKYOTEX SA. | Chief Administrative Officer | 01/04/2012 | - |
Director of Finance/CFO | 01/04/2012 | - | |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/01/2001 | - |
Statistiques
Internationale
Suisse | 4 |
France | 3 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director of Finance/CFO | 3 |
Chief Administrative Officer | 2 |
Sectorielle
Health Technology | 5 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
NOVARTIS AG | Health Technology |
ENGENE HOLDINGS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Commercial Services |
Alexion Pharma GmbH | |
Calliditas Therapeutics France SAS
Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
- Bourse
- Insiders
- Alexandre Grassin
- Expérience